|
Aisling Capital |
|
United States |
+1 (212) 651-6380 |
N/A |
|
|
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM)
|
BB Biotech Ventures |
|
Switzerland |
|
N/A |
|
|
|
|
CIP Capital LP |
|
United States |
+1 (610) 964-7875 |
N/A |
|
|
|
Lehman Brothers Holdings Inc |
|
United States |
|
N/A |
|
|
|
|
Merlin Nexus |
|
United States |
+1 (646) 227-5270 |
N/A |
|
|
|
Merrill Lynch Global Private Equity |
|
United States |
|
N/A |
|
|
|
Noble Financial Group |
|
United States |
+1 (314) 687-1075 |
N/A |
|
|
|
OrbiMed Advisors LLC |
American investment firm focused on making public and private investments in the healthcare and biotechnology industries. |
United States |
+1 (212) 739-6400 |
N/A |
|
|
|
Perseus LLC |
Merchant bank and private equity fund management company. |
United States |
+1 (212) 651-6400 |
N/A |
|
|
|
SV Life Sciences Advisers Inc |
|
United States |
+1 (617) 367-8100 |
N/A |
|
|
|
The Sprout Group |
Venture capital affiliate of Credit Suisse |
United States |
|
N/A |
|
|